| Title |
The Prevalence of DSM-IV Attention-Deficit/Hyperactivity Disorder: A Meta-Analytic Review
|
|---|---|
| Published in |
Neurotherapeutics, July 2012
|
| DOI | 10.1007/s13311-012-0135-8 |
| Pubmed ID | |
| Authors |
Erik G Willcutt |
X Demographics
The data shown below were collected from the profiles of 51 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 10 | 20% |
| United Kingdom | 6 | 12% |
| Netherlands | 2 | 4% |
| Spain | 2 | 4% |
| Bosnia and Herzegovina | 1 | 2% |
| Australia | 1 | 2% |
| Mauritius | 1 | 2% |
| New Zealand | 1 | 2% |
| India | 1 | 2% |
| Other | 3 | 6% |
| Unknown | 23 | 45% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 46 | 90% |
| Scientists | 3 | 6% |
| Science communicators (journalists, bloggers, editors) | 1 | 2% |
| Practitioners (doctors, other healthcare professionals) | 1 | 2% |
Mendeley readers
The data shown below were compiled from readership statistics for 1,615 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Netherlands | 6 | <1% |
| United Kingdom | 5 | <1% |
| Brazil | 4 | <1% |
| United States | 3 | <1% |
| Canada | 3 | <1% |
| Spain | 2 | <1% |
| Germany | 2 | <1% |
| Malaysia | 1 | <1% |
| India | 1 | <1% |
| Other | 6 | <1% |
| Unknown | 1582 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 252 | 16% |
| Student > Bachelor | 214 | 13% |
| Student > Ph. D. Student | 200 | 12% |
| Researcher | 159 | 10% |
| Student > Doctoral Student | 122 | 8% |
| Other | 242 | 15% |
| Unknown | 426 | 26% |
| Readers by discipline | Count | As % |
|---|---|---|
| Psychology | 395 | 24% |
| Medicine and Dentistry | 287 | 18% |
| Neuroscience | 104 | 6% |
| Agricultural and Biological Sciences | 64 | 4% |
| Social Sciences | 49 | 3% |
| Other | 215 | 13% |
| Unknown | 501 | 31% |
Attention Score in Context
This research output has an Altmetric Attention Score of 168. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 April 2024.
All research outputs
#246,233
of 25,766,791 outputs
Outputs from Neurotherapeutics
#27
of 1,319 outputs
Outputs of similar age
#1,090
of 177,417 outputs
Outputs of similar age from Neurotherapeutics
#3
of 13 outputs
Altmetric has tracked 25,766,791 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,319 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 18.8. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 177,417 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 13 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.